Business
Directorate Change
Directorate Change.
About this update from Genus Plc
[{"type":"text","content":"\n\nFor Immediate Release\n23 August 2023\nGenus plc\nNon-Executive Director Retirement\nGenus plc (LSE: GNS), a leading global animal genetics company, announces that Lykele van der Broek, Non-Executive Director, has informed the Company of his intention to step down from the Genus Board, effective from the conclusion of the 2023 Annual General Meeting on 22 November 2023, after nine years' service as a Non-Executive Director.\nRussell Reynolds has been retained and is in the process of identifying potential successors for Lykele.\nCommenting on the retirement, Iain Ferguson, Chairman of Genus, said:\n\"On behalf of the Board I want to acknowledge Lykele's significant contributions to the Board's deliberations, bringing to the fore his experience and knowledge as a leader in growing agricultural businesses across global markets. We thank him for his contributions, we will miss his keen insight and business acumen during our Board discussions and wish him well for the future.\"\nFor further information please contact:\nGenus:\nIain Ferguson, Chairman Tel: +44 (0)1256 345970\nJorgen Kokke, Chief Executive\n Buchanan:\nCharles Ryland /Chris Lane/ Verity Parker Tel: +44 (0)207 466 5000\nAbout Genus\nGenus creates advances to animal breeding and genetic improvement by applying biotechnology and sells added value products for livestock farming and food producers. Its technology is applicable across livestock species and is currently commercialised by Genus in the dairy, beef and pork food production sectors.\n \nGenus' worldwide sales are made in over seventy-five countries under the trademarks 'ABS' (dairy and beef cattle) and 'PIC' (pigs) and comprise semen, embryos and breeding animals with superior genetics to those animals currently in farms. Genus's customers' animals produce offspring with greater p...